Budesonide EP Impurity H
Product Description
CAT No.
ALN-B022009
CAS No.
313474-58-7
Mol. F.
C25H32O5
Mol. Wt.
412.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 16α,17-[(1RS)-Butylidenebis(oxy)]-21-hydroxypregna-1,4,9(11)-triene-3,20-dione (as per EP)
Smiles : C[C@@]12[C@@]3(C(CO)=O)[C@@](O[C@@](O3)([H])CCC)([H])C[C@@]1([H])[C@]4([H])CCC5=CC(C=C[C@]5(C)C4=CC2)=O
Inchi : InChI=1S/C25H36O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h10,16-18,20-22,26,28H,4-9,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1
Synonym : 9,11-Anhydro Budesonide ; Budesonide 9(11)-ene (USP)
Technical Data
Reference
A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers
By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, NagarajnFrom Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852
Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC
By Raghu, P. S. – From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6
Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy
By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha – From American Journal of Analytical Chemistry (2017), 8(7), 449-461
RFQ